Previous Close | 0.3500 |
Open | 0.3500 |
Bid | 0.1000 |
Ask | 0.3000 |
Strike | 97.50 |
Expire Date | 2024-07-19 |
Day's Range | 0.3500 - 0.3500 |
Contract Range | N/A |
Volume | |
Open Interest | 37 |
BD's (BDX) receipt of the FDA's clearance for the use of self-collected vaginal specimens for HPV testing is likely to improve screening access to a wider female population.
Butterfly Network (BFLY) uses proprietary Ultrasound-on-Chip technology to streamline the bladder scanning process.
Investors remain optimistic about AMN Healthcare's (AMN) broad array of services.